"For over two decades, CIT has been dedicated to assisting pharmaceutical companies find new cures to help patients better manage their healthcare."

During the past decade, CITrials conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 18 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 17 clinical trials were completed. i.e. 106.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CITrials" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CITrials" #1 collaborator was "H. Lundbeck A/S" with 3 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Clinilabs, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "CITrials" are "Depressive Disorder, Major" (5 trials), "Alzheimer Disease" (4 trials), "Schizophrenia" (4 trials), "Bipolar I Disorder" (3 trials) and "Manic Episode" (2 trials). Many other conditions were trialed in "CITrials" in a lesser frequency.

Most popular intervention types in "CITrials" are "Drug" (33 trials), "Other" (3 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Brexpiprazole" (4 trials), "Rapastinel" (4 trials), "Placebo capsule" (2 trials) and "TNX-102 SL" (2 trials). Other intervention names were less common.

The vast majority of trials in "CITrials" are 35 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CITrials". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in CITrials, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CITrials, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".